Acology Continues Strong Pace, Highlights of 10Q in Letter to Shareholders
May 15, 2017 12:32 pm UTC| Business
CORONA, Calif., May 15, 2017 -- A Letter from CEO Curt Fairbrother Dear Shareholders: With Friday’s release of our 10Q our company’s health and strength continues to be decisively displayed along with the...
May 15, 2017 12:32 pm UTC| Business
HOFFMAN ESTATES, Ill., May 15, 2017 -- CDK Global, Inc. (“CDK”) announced today its entry into an accelerated share repurchase (“ASR”) agreement with Bank of America Merrill Lynch (“BofAML”) to purchase $350 million of...
May 15, 2017 12:32 pm UTC| Business
HOFFMAN ESTATES, Ill., May 15, 2017 -- CDK Global, Inc. (“CDK”) announced today its entry into an accelerated share repurchase (“ASR”) agreement with Bank of America Merrill Lynch (“BofAML”) to purchase $350 million of...
May 15, 2017 12:32 pm UTC| Business
HOFFMAN ESTATES, Ill., May 15, 2017 -- CDK Global, Inc. (“CDK”) announced today its entry into an accelerated share repurchase (“ASR”) agreement with Bank of America Merrill Lynch (“BofAML”) to purchase $350 million of...
May 15, 2017 12:32 pm UTC| Business
NEWTOWN, Pa., May 15, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a...
May 15, 2017 12:32 pm UTC| Business
NEWTOWN, Pa., May 15, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a...
May 15, 2017 12:32 pm UTC| Business
NEWTOWN, Pa., May 15, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a...